Updates are available Erratum dated 2016-10-06
Click to view Erratum: https://doi.org/10.1038/nm1016-1192a
-
Authors
Vaccari, Monica
Gordon, Shari N
Fourati, Slim
Schifanella, Luca
Liyanage, Namal P M
Cameron, Mark
Keele, Brandon F
Shen, Xiaoying
Tomaras, Georgia D
Billings, Erik
Rao, Mangala
Chung, Amy W
Dowell, Karen G
Bailey-Kellogg, Chris
Brown, Eric P
Ackerman, Margaret E
Vargas-Inchaustegui, Diego A
Whitney, Stephen
Doster, Melvin N
Binello, Nicolo
Pegu, Poonam
Montefiori, David C
Foulds, Kathryn
Quinn, David S
Donaldson, Mitzi
Liang, Frank
Loré, Karin
Roederer, Mario
Koup, Richard A
McDermott, Adrian
Ma, Zhong-Min
Miller, Christopher J
Phan, Tran B
Forthal, Donald N
Blackburn, Matthew
Caccuri, Francesca
Bissa, Massimiliano
Ferrari, Guido
Kalyanaraman, Vaniambadi
Ferrari, Maria G
Thompson, DeVon
Robert-Guroff, Marjorie
Ratto-Kim, Silvia
Kim, Jerome H
Michael, Nelson L
Phogat, Sanjay
Barnett, Susan W
Tartaglia, Jim
Venzon, David https://orcid.org/0000-0002-8990-158X
Stablein, Donald M
Alter, Galit
Sekaly, Rafick-Pierre
Franchini, Genoveffa
- License Information
-
More Information
Article History
Received: 25 November 2015
Accepted: 5 April 2016
First Online: 30 May 2016
Change Date: 16 June 2016
Change Type: Corrigendum
Change Details: In the version of this article initially published online, an affiliation for Luca Schifanella was omitted and there was an error in the description of the phenotypic analyses of plasmablasts in the Online Methods. The error has been corrected for the print, PDF and HTML versions of this article.
Competing interests
: G. Franchini and J.Tartaglia are authors on patent US 5766598 A: Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products (issued June 16, 1998), which is jointly held by Sanofi Pasteur and the US government. S.P. is an employee of Sanofi Pasteur; M.G.F. is an employee of Advanced Bioscience Laboratories; D.M.S. is an employee of The EMMES Corporation; and S.W.B. was an employee of Novartis Vaccines and Diagnostics, Inc. S.W.B. is now an employee of and owns stock in GSK Vaccines.
